Skip to main content
Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.87
-0.21 (-1.70%)
Mar 9, 2026, 1:38 PM EDT - Market open

Crescent Biopharma Revenue

In the year 2025, Crescent Biopharma had annual revenue of $10.84M. Crescent Biopharma had revenue of $10.84M in the quarter ending December 31, 2025.

Revenue (ttm)
$10.84M
Revenue Growth
n/a
P/S Ratio
36.75
Revenue / Employee
$264,488
Employees
41
Market Cap
394.08M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202510.84M--
Dec 31, 2024---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CBIO News

More News